Form 4: RenovoRx Director Una S. Ryan Acquires Stock Options
SEC Form 4 Filing
Director Una S. Ryan acquired 25,099 stock options in RenovoRx, Inc. on October 1, 2024, according to a Form 4 filing.
Summary
- On October 1, 2024, Una S. Ryan, a director of RenovoRx, Inc., acquired 25,099 stock options.
- The options have an exercise price of $1.02.
- The options vest in 12 equal monthly installments starting November 1, 2024.
- The options expire on October 1, 2034.
- Following the transaction, Ryan directly owns 25,099 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock option grants, which is neither particularly positive nor negative.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of earliest transaction: acquisition of stock options. |
| 10/01/2024 | Date of stock option grant. |
| 10/02/2024 | Date of Form 4 filing. |
| 11/01/2024 | Vesting start date for the stock options. |
| 10/01/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.